Therapeutic potential of umbelliferone in the management of periodontal disease

Periodontal disease has a multifactorial etiology. The immune response to bacterial infection leads to the activation of osteoclasts, resulting in the resorption of alveolar bone and, ultimately, tooth loss. Standard clinical treatments typically include scaling and root planing, which may or may not involve surgical procedures and are often supplemented with antibiotics and antiseptic chlorhexidine to control the growth of periodontal pathogens. However, research indicates that chlorhexidine can produce adverse effects, and many periodontal pathogens have developed antibiotic resistance. Given these challenges, bioactive compounds derived from medicinal plants, particularly coumarins, present promising alternative treatment options. This study seeks to explore the therapeutic potential of umbelliferone for the treatment of periodontitis using the Orbit patent database, employing the search syntax: ((umbelliferone)/TI/AB/CLMS/KEYW AND (A61Q-011/00)/IPC/CPC). Umbelliferone has shown potential in developing advanced therapeutic products for periodontal treatment and preventing periodontitis. Its remarkable biological properties, may significantly enhance clinical strategies for managing periodontitis.